• 企業・知財を促進
    • スタートアップ企業一覧
    • IP&技術一覧
  • ヘルプを取得
    • 質問を検索
    • プロジェクトを投稿
    • 専門家Directoryを検索
  • リソース
    • ドキュメントセンター
    • 特許を検索
    • 専門家の記事・ブログ
  • ニュース
    • Tech&IPニュース
  • マイアカウント
  • ログイン
  • 専門家向け

特許

68,026 件
全IP種別
PATENTFIELDで検索
IPを掲載
権利維持

Endothelialization of impla...

Endothelialization of implantable medical devices

係属中

Hyaluronan

Hyaluronan (also called hyaluronic acid or hyaluronate or HA) is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique amo...

係属中

Pollen allergy

Nasal allergy to pollen is called pollinosis, and allergy specifically to grass pollen is called hay fever. Generally, pollens that cause allergies are those of anemophilous plants (pollen is dispe...

係属中

Artifact removal in medical...

Artifact removal in medical images

係属中

Drug-induced nausea

Drug-induced nausea

権利維持

LIGHT

Tumor necrosis factor ligand superfamily member 14 is a protein that in humans is encoded by the TNFSF14 gene.[1][2] TNFSF14 has also been designated as CD258,[citation needed] as well as LIGHT.[3]...

係属中

Drug-induced nausea

Drug-induced nausea

係属中

Production of methane from CO2

Naturally occurring methane is mainly produced by the process of methanogenesis. This multistep process is used by microorganisms as an energy source. The net reaction is: CO2 + 8 H+ + 8 e− → CH...

権利維持

Lubricant

A lubricant is a substance introduced to reduce friction between surfaces in mutual contact, which ultimately reduces the heat generated when the surfaces move. It may also have the function of tra...

係属中

Detecting organisms using s...

Detecting organisms using stochastic confinement

権利維持

Liver X receptor agonists

LXR agonists are effective for treatment of murine models of atherosclerosis, diabetes, anti-inflammation, and Alzheimer's disease. Treatment with LXR agonists (hypocholamide, T0901317, GW3965, or ...

係属中

Assaying blood clotting

Coagulation (clotting) is the process by which blood changes from a liquid to a gel. It potentially results in hemostasis, the cessation of blood loss from a damaged vessel, followed by repair. The...

係属中

Electrolytic production of ...

The conversion of alumina to aluminum metal is achieved by the Hall-Héroult process. In this energy-intensive process, a solution of alumina in a molten (950 and 980 °C (1,740 and 1,800 °F)) mixtur...

係属中

Reducing cell death

Cell death is the event of a biological cell ceasing to carry out its functions. This may be the result of the natural process of old cells dying and being replaced by new ones, or may result from ...

権利維持

NKT cell

Natural killer T (NKT) cells are a heterogeneous group of T cells that share properties of both T cells and natural killer (NK) cells. Many of these cells recognize the non-polymorphic CD1d molecul...

権利維持

Hypothermia

Hypothermia (from Greek ὑποθερμία) is a condition in which the body's core temperature drops below that required for normal metabolism and body functions. This is generally considered to be less th...

権利維持

Plants modified with mini-c...

In 2006, scientists demonstrated the successful use of telomere truncation in maize plants to produce minichromosomes that could be utilized as a platform for inserting genes into the plant genome[...

係属中

Engineered herpes simplex v...

Engineered herpes simplex virus

係属中

APOA1

Apolipoprotein A-I is a protein that in humans is encoded by the APOA1 gene.[1][2] It has a specific role in lipid metabolism. Recent report suggest that APOA1 mRNA is regulated by endogenously exp...

係属中

Myelination disorders

A demyelinating disease is any disease of the nervous system in which the myelin sheath of neurons is damaged.[1] This damage impairs the conduction of signals in the affected nerves. In turn, the ...

  • 最初
  • 前
  • …
  • 1761
  • 1762
  • 1763
  • 1764
  • 1765
  • 1766
  • 1767
  • 1768
  • 1769
  • …
  • 次
  • 最後
イノベーションと知的財産権のためのone-stop shop 今すぐ参加

IP Nexusについて

IP Nexusは、大学・研究機関と連携して新規技術の潜在的なビジネス価値を解明し、技術シーズ・スタートアップ企業を成功へと導かせ、投資家やその他のステークホルダーに貴重なリターンを生み出す知的財産(IP)の商業化企業です。テクノロジーとライフサイエンスにフォーカスしたハイポテンシャルな発明を早期に特定してコマーシャルディレクション、資金調達の専門知識およびマネジメント能力を提供します。アジア地域に特化した専門知識によりアジア地域にフォーカスしています。

免責事項

IP Nexusは、Ask an ExpertとService Marketplaceを提供しています。Ask an ExpertとService Marketplaceは、インタラクティブなオンラインサービスであり、迅速かつ容易にビジネスのための法的相談や法的サービスを見つけることができます。IP Nexusは、法律事務所ではなく、法的助言、法律家の斡旋などの法的サービスを提供することはなく、自ら法的代理を行うことはありません。

コンテンツ

  • 価格
  • よくある質問
  • 知的財産権(IP)の保護
  • 知的財産権(IP)の種類
  • 知的財産権(IP)に関する申し立て
  • 我々のチームについて
  • スタートアップ
  • お問い合せ
  • ブランド資産
  • 利用規約
  • プライバシーポリシー
  • PATENTFIELDで特許を検索

ニュースレター

購読

言語設定

© 2026 IP Nexus. All Rights Reserved.

レポート内容

      問い合わせフォーム